Trending Now
Sigilon Therapeutics Inc (NASDAQ: SGTX) Phase 1/22 Study of SIG-OO1 Placed...
Sigilon Therapeutics Inc (NASDAQ: SGTX), a biotechnology firm that develops functional cures for chronic diseases via its Shielded Living Therapeutics, has recently placed its...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Hoth Therapeutics Inc. (NASDAQ: HOTH) Releases Preliminary Results Of The Study...
Hoth Therapeutics Inc. (NASDAQ: HOTH) has released proof of concept results from an Alzheimer's disease animal model supporting HT-ALZ's therapeutic potential. The study was...
MAKE IT MODERN
LATEST REVIEWS
Airbnb Inc (ABNB) exits China
According to two sources familiar with the situation, Airbnb is shutting down its domestic business in China. Employees in the country will...
MAKE IT MODERN
PERFORMANCE TRAINING
Alkido Pharma Inc. (NASDAQ:AIKI) Announce Updates From Cogia BioTech Efforts To Use AI In...
Alkido Pharma Inc. (NASDAQ:AIKI) and its research partner, Cogia BioTech Ltd, have delivered important updates in their efforts to expedite the study of Pancreatic...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) Closes The Acquisition of Virex Health Inc
Sorrento Therapeutics Inc. (NASDAQ: SRNE) has completed the purchase of Boston, MA-based firm Virex Health Inc. On February 1, 2022, Virex spun out of...
ChargePoint Holdings Inc (NYSE:CHPT) unusual options activity indicates increased interest
CPI number that we see this morning is going to make an impact in the market one way or another. Stocks have...
Assembly Biosciences Inc. (NASDAQ: ASMB) Discontinues ABI-H2158 Development Following Elevated ALT Levels
Assembly Biosciences Inc. (NASDAQ: ASMB) has announced that it will discontinue ABI-H2158 (2158) development t after observing elevated ALT levels consistent with treatment-induced hepatoxicity...
Chinese stocks look to bounce off the charts (BABA,BIDU)
It's been a challenging time to be a short and with Trump pushing for more interest rate cuts...
MAKE IT MODERN
